Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study.
Di Gregorio M, Torri Clerici VLA, Fenu G, Gaetani L, Gallo A, Cavalla P, Ragonese P, Annovazzi P, Gajofatto A, Prosperini L, Landi D, Nicoletti CG, Di Carmine C, Totaro R, Nociti V, De Fino C, Ferraro D, Tomassini V, Tortorella C, Righini I, Amato MP, Manni A, Paolicelli D, Iaffaldano P, Lanzillo R, Moccia M, Buttari F, Fantozzi R, Cerqua R, Zagaglia S, Farina D, De Luca G, Buscarinu MC, Pinardi F, Cocco E, Gasperini C, Solaro CM, Di Filippo M. Di Gregorio M, et al. Among authors: paolicelli d. Eur J Neurol. 2021 Apr;28(4):1299-1307. doi: 10.1111/ene.14672. Epub 2021 Jan 12. Eur J Neurol. 2021. PMID: 33305459
Age-related disability in multiple sclerosis.
Trojano M, Liguori M, Bosco Zimatore G, Bugarini R, Avolio C, Paolicelli D, Giuliani F, De Robertis F, Marrosu MG, Livrea P. Trojano M, et al. Among authors: paolicelli d. Ann Neurol. 2002 Apr;51(4):475-80. doi: 10.1002/ana.10147. Ann Neurol. 2002. PMID: 11921053
Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis.
Tortorella C, Bellacosa A, Paolicelli D, Fuiani A, Di Monte E, Simone IL, Giaquinto P, Livrea P, Trojano M. Tortorella C, et al. Among authors: paolicelli d. J Neurol Sci. 2005 Dec 15;239(1):95-9. doi: 10.1016/j.jns.2005.08.006. Epub 2005 Oct 4. J Neurol Sci. 2005. PMID: 16209877
Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score.
Bergamaschi R, Quaglini S, Trojano M, Amato MP, Tavazzi E, Paolicelli D, Zipoli V, Romani A, Fuiani A, Portaccio E, Berzuini C, Montomoli C, Bastianello S, Cosi V. Bergamaschi R, et al. Among authors: paolicelli d. J Neurol Neurosurg Psychiatry. 2007 Jul;78(7):757-9. doi: 10.1136/jnnp.2006.107052. Epub 2007 Jan 12. J Neurol Neurosurg Psychiatry. 2007. PMID: 17220286 Free PMC article.
New natural history of interferon-beta-treated relapsing multiple sclerosis.
Trojano M, Pellegrini F, Fuiani A, Paolicelli D, Zipoli V, Zimatore GB, Di Monte E, Portaccio E, Lepore V, Livrea P, Amato MP. Trojano M, et al. Among authors: paolicelli d. Ann Neurol. 2007 Apr;61(4):300-6. doi: 10.1002/ana.21102. Ann Neurol. 2007. PMID: 17444502 Clinical Trial.
Postmarketing evidence of disease-modifying drugs in multiple sclerosis.
Trojano M, Paolicelli D, Fuiani A, Pellegrini F, Iaffaldano P, Direnzo V, D'Onghia M. Trojano M, et al. Among authors: paolicelli d, d onghia m. Neurol Sci. 2008 Sep;29 Suppl 2:S225-6. doi: 10.1007/s10072-008-0944-z. Neurol Sci. 2008. PMID: 18690499 Review.
Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment.
Trojano M, Pellegrini F, Paolicelli D, Fuiani A, Zimatore GB, Tortorella C, Simone IL, Patti F, Ghezzi A, Portaccio E, Rossi P, Pozzilli C, Salemi G, Lugaresi A, Bergamaschi R, Millefiorini E, Clerico M, Lus G, Vianello M, Avolio C, Cavalla P, Iaffaldano P, Direnzo V, D'Onghia M, Lepore V, Livrea P, Comi G, Amato MP; Italian Multiple Sclerosis Database Network Group. Trojano M, et al. Among authors: paolicelli d, d onghia m. J Neurol Sci. 2009 Nov 15;286(1-2):109-13. doi: 10.1016/j.jns.2009.06.036. Epub 2009 Jul 16. J Neurol Sci. 2009. PMID: 19615696 Clinical Trial.
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis.
Trojano M, Pellegrini F, Paolicelli D, Fuiani A, Zimatore GB, Tortorella C, Simone IL, Patti F, Ghezzi A, Zipoli V, Rossi P, Pozzilli C, Salemi G, Lugaresi A, Bergamaschi R, Millefiorini E, Clerico M, Lus G, Vianello M, Avolio C, Cavalla P, Lepore V, Livrea P, Comi G, Amato MP; Italian Multiple Sclerosis Database Network (MSDN) Group. Trojano M, et al. Among authors: paolicelli d. Ann Neurol. 2009 Oct;66(4):513-20. doi: 10.1002/ana.21757. Ann Neurol. 2009. PMID: 19847899
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis.
Amato MP, Portaccio E, Ghezzi A, Hakiki B, Zipoli V, Martinelli V, Moiola L, Patti F, La Mantia L, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, Di Tommaso V, Paolicelli D, Marrosu MG, Comi G, Pellegrini F, Trojano M; MS Study Group of the Italian Neurological Society. Amato MP, et al. Among authors: paolicelli d. Neurology. 2010 Nov 16;75(20):1794-802. doi: 10.1212/WNL.0b013e3181fd62bb. Neurology. 2010. PMID: 21079181
Multiple sclerosis in Italy: cost-of-illness study.
Patti F, Amato MP, Trojano M, Solaro C, Pappalardo A, Zipoli V, Portaccio E, Paolicelli D, Paolillo A, Mennini FS, Marcellusi A, Ricci C, Battaglia MA. Patti F, et al. Among authors: paolicelli d. Neurol Sci. 2011 Oct;32(5):787-94. doi: 10.1007/s10072-011-0499-2. Epub 2011 Mar 16. Neurol Sci. 2011. PMID: 21409509
143 results